## Abstract We have measured the gain of the vestibuloocular reflex (VOR) in darkness and its cancellation by fixation in 37 patients with Parkinson's disease (PD), 26 patients with multiple system atrophy (MSA), 11 patients with progressive supranuclear palsy (PSP), and 19 normal volunteers. The c
Nocturnal body core temperature falls in Parkinson's disease but not in multiple-system atrophy
✍ Scribed by G. Pierangeli; F. Provini; P. Maltoni; G. Barletta; M. Contin; E. Lugaresi; P. Montagna; P. Cortelli
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 56 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0885-3185
- DOI
- 10.1002/mds.1039
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
OBJECTIVE:
To evaluate whether the circadian rhythm of body core temperature (CRT°) can differentiate Multiple‐System Atrophy (MSA) from Idiopathic Parkinson's disease (IPD).
METHODS:
We evaluated 14 patients with probable MSA, seven with IPD, and eight controls. After a preliminary evaluation of cardiovascular autonomic function, rectal temperature and sleep‐wake cycle were monitored continuously for 48 hours in a temperature‐controlled room, at constant bed rest with controlled food intake and fixed light‐dark schedule.
RESULTS:
MSA patients showed cardiovascular autonomic sympathetic and parasympathetic failure. IPD had normal cardiovascular autonomic function. A 24‐hour rhythm of body core temperature (BcT°) was present in all subjects. IPD had CRT° comparable to controls. In MSA the mesor was higher and mean BcT° of each hour was significantly higher from 11 p.m. to 7 a.m. The analysis of mean BcT° during the different sleep phases showed significantly higher values during both NREM (1–2, 3–4) and REM sleep stages in MSA.
CONCLUSIONS:
The physiological nocturnal fall of BcT° is blunted in MSA patients mainly because BcT° did not decrease during sleep. This CRT° pattern is not justified by differences in sleep structure and may reflect an impairment of central sympathetic nervous system function. © 2001 Movement Disorder Society.
📜 SIMILAR VOLUMES
## Abstract The 42‐amino–acid isoform of β‐amyloid Aβ42 in the cerebrospinal fluid (CSF) has recently been proposed as a biochemical marker for Alzheimer's disease (AD) and subcortical white‐matter dementia (SWD). In both of these conditions, concentration of CSF‐Aβ42 is reduced. We quantified CSF‐